SEC
|
Robertson Judith J.
|
N/A
|
|
+81K
|
$0.85
|
+$68.80K
|
|
SEC
|
Robertson Judith J.
|
N/A
|
|
+10K
|
$0.85
|
+$8.66K
|
|
SEC
|
Maderis Gail J
|
N/A
|
|
+25K
|
$0.71
|
+$17.89K
|
|
SEC
|
Maderis Gail J
|
N/A
|
|
+175K
|
$0.67
|
+$117.11K
|
|
SEC
|
Robertson Judith J.
|
N/A
|
|
+65K
|
$0.39
|
+$25.35K
|
|
SEC
|
AZAB MOHAMMAD
|
N/A
|
|
+30K
|
$0.39
|
+$11.70K
|
|
SEC
|
Farfel Gail M
|
N/A
|
|
+55K
|
$0.40
|
+$22.08K
|
|
SEC
|
AZAB MOHAMMAD
|
N/A
|
|
+30K
|
$0.41
|
+$12.30K
|
|
SEC
|
Farfel Gail M
|
N/A
|
|
+21K
|
$0.40
|
+$8.28K
|
|
SEC
|
Farfel Gail M
|
N/A
|
|
+24K
|
$0.41
|
+$9.88K
|
|
SEC
|
Robertson Judith J.
|
N/A
|
|
+200K
|
$0.59
|
+$118.00K
|
|
SEC
|
BENITO SIMON X
|
N/A
|
|
+20K
|
$1.02
|
+$20.40K
|
|
SEC
|
Joice Judy R
|
Sr. VP Operations & Corp QA
|
|
-60K
|
$1.72
|
-$103.44K
|
|
SEC
|
Bleichroeder LP
|
N/A
|
|
-250K
|
$1.68
|
-$420.00K
|
|
SEC
|
Bleichroeder LP
|
N/A
|
|
-39K
|
$2.50
|
-$98.47K
|
|
SEC
|
Bleichroeder LP
|
N/A
|
|
+227K
|
$1.68
|
+$382.20K
|
|
SEC
|
First Eagle Holdings, Inc.
|
N/A
|
|
+4M
|
$0.52
|
+$2.08M
|
|
SEC
|
SAXE JON S
|
N/A
|
|
+25K
|
$0.55
|
+$13.75K
|
|
SEC
|
SAXE JON S
|
N/A
|
|
+30K
|
$0.63
|
+$18.90K
|
|
SEC
|
SAXE JON S
|
N/A
|
|
+50K
|
$0.70
|
+$35.00K
|
|
SEC
|
SAXE JON S
|
N/A
|
|
+25K
|
$0.82
|
+$20.50K
|
|
SEC
|
Arenberg Michael
|
Chief Financial Officer
|
|
+10K
|
$0.80
|
+$8.00K
|
|
SEC
|
BROWN JAMES E
|
President & CEO
|
|
+10K
|
$0.81
|
+$8.10K
|
|
SEC
|
Blaschke Terrence F
|
N/A
|
|
+25K
|
$0.82
|
+$20.50K
|
|
SEC
|
BENITO SIMON X
|
N/A
|
|
+25K
|
$0.82
|
+$20.50K
|
|
SEC
|
HOFFMANN DAVE
|
N/A
|
|
+95K
|
$1.04
|
+$98.80K
|
|
SEC
|
First Eagle Holdings, Inc.
|
N/A
|
|
+2.5M
|
$1.15
|
+$2.88M
|
|
SEC
|
First Eagle Holdings, Inc.
|
N/A
|
|
+5.5M
|
$1.25
|
+$6.88M
|
|
SEC
|
HOFFMANN DAVE
|
N/A
|
|
+200K
|
$1.25
|
+$250.00K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+160K
|
$1.25
|
+$200.00K
|
|
SEC
|
Blaschke Terrence F
|
N/A
|
|
+3K
|
$1.35
|
+$4.05K
|
|
SEC
|
Neukermans Armand
|
N/A
|
|
+18K
|
$1.39
|
+$25.02K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+70K
|
$1.41
|
+$98.70K
|
|
SEC
|
BROWN JAMES E
|
President & CEO
|
|
+20K
|
$1.33
|
+$26.60K
|
|
SEC
|
First Eagle Value in Biotechnology Master Fund, Ltd.
|
N/A
|
|
+300K
|
$1.37
|
+$411.14K
|
|
SEC
|
First Eagle Value in Biotechnology Master Fund, Ltd.
|
N/A
|
|
+952K
|
$1.79
|
+$1.70M
|
|
SEC
|
Neukermans Armand
|
N/A
|
|
+20K
|
$2.40
|
+$48.00K
|
|
SEC
|
Arnhold & S. Bleichroeder Holdings, Inc.
|
N/A
|
|
+1.7M
|
$1.70
|
+$2.84M
|
|
SEC
|
BENITO SIMON X
|
N/A
|
|
+40K
|
$1.81
|
+$72.40K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+226K
|
$1.65
|
+$372.24K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+380K
|
$1.57
|
+$596.60K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+73K
|
$1.00
|
+$72.70K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+136K
|
$0.92
|
+$125.13K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+714K
|
$1.40
|
+$1.00M
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+75K
|
$1.20
|
+$90.00K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+25K
|
$1.15
|
+$28.75K
|
|
SEC
|
BROWN JAMES E
|
President & CEO
|
|
+30K
|
$0.80
|
+$24.00K
|
|
SEC
|
SAXE JON S
|
N/A
|
|
+15K
|
$0.91
|
+$13.65K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+100K
|
$1.01
|
+$101.00K
|
|
SEC
|
SAXE JON S
|
N/A
|
|
+7.8K
|
$0.97
|
+$7.58K
|
|
SEC
|
SAXE JON S
|
N/A
|
|
+5K
|
$1.00
|
+$5.00K
|
|
SEC
|
Neukermans Armand
|
N/A
|
|
+20K
|
$0.88
|
+$17.60K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+35K
|
$0.79
|
+$27.65K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+41K
|
$0.79
|
+$32.07K
|
|
SEC
|
HOFFMANN DAVE
|
N/A
|
|
+25K
|
$0.81
|
+$20.25K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+69K
|
$0.77
|
+$52.93K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+46K
|
$0.75
|
+$34.33K
|
|
SEC
|
BROWN JAMES E
|
President & CEO
|
|
+20K
|
$0.79
|
+$15.80K
|
|
SEC
|
Blaschke Terrence F
|
N/A
|
|
+3K
|
$3.16
|
+$9.48K
|
|
SEC
|
BENITO SIMON X
|
N/A
|
|
+5K
|
$3.61
|
+$18.05K
|
|
SEC
|
BROWN JAMES E
|
President & CEO
|
|
+1K
|
$4.09
|
+$4.09K
|
|
SEC
|
BENITO SIMON X
|
N/A
|
|
+5K
|
$4.60
|
+$23.00K
|
|
SEC
|
HOGAN MATTHEW J
|
Chief Financial Officer
|
|
+10K
|
$3.98
|
+$39.80K
|
|
SEC
|
BROWN JAMES E
|
President & CEO
|
|
+10K
|
$3.71
|
+$37.10K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+50K
|
$3.83
|
+$191.50K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+20K
|
$4.95
|
+$99.00K
|
|
SEC
|
BROWN JAMES E
|
President & CEO
|
|
-294K
|
$5.00
|
-$1.47M
|
|
SEC
|
CHAN TAI WAH
|
VP Pharma. Research & Develp.
|
|
-10K
|
$5.00
|
-$50.00K
|
|
SEC
|
LIU JEAN I
|
Sr. VP & General Counsel
|
|
-22K
|
$5.00
|
-$111.28K
|
|
SEC
|
Neukermans Armand
|
N/A
|
|
+75K
|
$3.46
|
+$259.50K
|
|
SEC
|
BENITO SIMON X
|
N/A
|
|
+5K
|
$3.27
|
+$16.35K
|
|
SEC
|
BENITO SIMON X
|
N/A
|
|
+5K
|
$3.05
|
+$15.25K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+40K
|
$2.97
|
+$118.80K
|
|
SEC
|
SCHRECK THOMAS A
|
Chief Financial Officer
|
|
+3K
|
$1.40
|
+$4.20K
|
|
SEC
|
THEEUWES FELIX
|
Chairman and CSO
|
|
+71K
|
$1.40
|
+$99.40K
|
|
SEC
|
HOFFMANN DAVE
|
N/A
|
|
+5K
|
$3.24
|
+$16.20K
|
|
SEC
|
TAYLOR MICHAEL J
|
VP, Non Clinical Research
|
|
-4.4K
|
$3.10
|
-$13.64K
|
|
SEC
|
TAYLOR MICHAEL J
|
VP, Non Clinical Research
|
|
-4.4K
|
$3.00
|
-$13.20K
|
|